May 20, 2010 -
Tanning Beds Increase Risk of Developing Melanoma Four Fold Tanning beds are popular devices used by millions of adults across North America for esthetic purposes. This population based case controlled study was able to show a massive increase in risk (4 fold) for those individuals who were regular users of these devices. The risk increased with increasing years of use. We should be considering these devices as carcinogens and warnings should be required to be posted in businesses who sell these tanning treatments. read more...
Metastatic Multiple Myeloma is a challenging disease to treat with poor survival even with chemotherapy treatment. Thymosin alpha 1 is an isolated peptide extract from calves thymus that has immunomodulatory properties particularly in T cells. In this study it was shown that Thymosin alpha 1 in combination with decarbazine increased overall survival and reducd diseases progression.
Moderate selenium supplementation during radiation therapy in patients undergoing radiation therapy for cervical or uterine cancer is effective in reducing the number of episodes and severity of radiation induced diarrhea.
Traditionally, chelidonium was used to eliminate corneal films of the eye and as a foot refresher by gypsies. Alchemists believed that the herb was beneficial for jaundice indicated by its yellow hue.
Native to the East, North Africa, Europe, the roots and aerial parts of the plant contain various phytochemicals that lead to its function in reducing inflammation, pain, water retention, promoting liver and gallbladder function and detoxifying the blood.
The alkaloids found in chelidonium have been shown to inhibit cell growth through apoptosis of cancer cells, enhance immune function, and stimulate dopaminergic activity. Extracts of chelidonium administered to cultured leukemia cells and hepatocarcinogenesis-induce mice were found to offer chemopreventative actions through the plant’s antioxidant, antitumor and hepatoprotective activities. The phytoconstituents found in chelidonium have known cytotoxic and antioxidant activity, thus have the potential of serving as an important chemotherapeutic agent.
Preliminary clinical research has demonstrated the use of chelidonium in the treatment of various cancers. A partially synthetic model of chelidonine, one of chelidonium’s main constituents, has been shown to improve the survival time of those with colorectal, bladder, pancreatic, or breast cancer when administered intravenously.